Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ)

8.22 -0.31 (-3.63%) At close: 03:04PM CST

Sichuan Goldstone Asia Pharmaceutical Inc.

A1, Dadi New Guanghua Plaza
8th Floor No. 8 Jiayuan Road Qingyang District
Chengdu 610072
China
86 28 8708 6807
https://www.goldstone-group.com

Sector(s): Industrials
Industry: Industrial Distribution
Full-time employees: 1,962

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Baokang Wei	Chairman & GM	N/A	N/A	1968
Mr. Qiang Lin	Deputy GM, Secretary of the Board & Non-Independent Director	N/A	N/A	1964
Mr. Shaojiang Chen	Deputy General Manager	N/A	N/A	1963
Mr. Zhihao Wang	Deputy General Manager	N/A	N/A	1974
Mr. Qing Guo Wang	Chief Financial Officer	N/A	N/A	1975

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Sichuan Goldstone Asia Pharmaceutical Inc. engages in the research, development, and sale of medicines and health products in China. It produces and sells plastic composite pipes, pipe fittings and equipment, as well as develops vacuum coating, industrial machinery, pipe fitting molds, construction equipment, and special equipment. The company produces, installs, and maintains special equipment. It also imports and exports spare parts, raw, and auxiliary materials. Sichuan Goldstone Asia Pharmaceutical Inc. was founded in 2001 and is based in Chengdu, China.

Corporate governance

Sichuan Goldstone Asia Pharmaceutical Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.